Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis

Cell

Volumn 168, Issue 6, 2017, Pages 1101-1113.e13

  Boire, Adrienne ^a   Zou, Yilong ^a   Shieh, Jason ^a   Macalinao, Danilo G ^a   Pentsova, Elena ^a   Massagué, Joan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

amphiregulin; brain metastasis; carcinomatous meningitis; cerebrospinal fluid breast cancer; choroid plexus; complement C3; GDNF; leptomeningeal metastasis; lung cancer; PDGF

Indexed keywords

AMPHIREGULIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT RECEPTOR; MITOGENIC AGENT; UNCLASSIFIED DRUG; CD11B ANTIGEN; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; BREAST CANCER CELL LINE; CANCER GROWTH; CANCER INFILTRATION; CANCER MODEL; CANCER RECURRENCE; CEREBROSPINAL FLUID; CHOROID PLEXUS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; LUNG CANCER CELL LINE; MALE; MENINGEAL METASTASIS; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; BREAST TUMOR; GENETICS; LUNG TUMOR; MENINGIOMA; METABOLISM; METASTASIS; PATHOLOGY; SECONDARY; VASCULARIZATION;

ANIMALS; BREAST NEOPLASMS; CEREBROSPINAL FLUID; CHOROID PLEXUS; COMPLEMENT C3; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MACROPHAGE-1 ANTIGEN; MENINGEAL NEOPLASMS; MICE; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; UP-REGULATION;

EID: 85014865580     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2017.02.025     Document Type: Article

References (64)

1. Acharyya, S., Oskarsson, T., Vanharanta, S., Malladi, S., Kim, J., Morris, P.G., Manova-Todorova, K., Leversha, M., Hogg, N., Seshan, V.E., et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 150 (2012), 165–178.
2. Addison, C.L., Ding, K., Zhao, H., Le Maître, A., Goss, G.D., Seymour, L., Tsao, M.S., Shepherd, F.A., Bradbury, P.A., Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR.21. J. Clin. Oncol. 28 (2010), 5247–5256.
3. Ames, R.S., Li, Y., Sarau, H.M., Nuthulaganti, P., Foley, J.J., Ellis, C., Zeng, Z., Su, K., Jurewicz, A.J., Hertzberg, R.P., et al. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J. Biol. Chem. 271 (1996), 20231–20234.
4. Ames, R.S., Lee, D., Foley, J.J., Jurewicz, A.J., Tornetta, M.A., Bautsch, W., Settmacher, B., Klos, A., Erhard, K.F., Cousins, R.D., et al. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J. Immunol. 166 (2001), 6341–6348.
5. An, Y.J., Cho, H.R., Kim, T.M., Keam, B., Kim, J.W., Wen, H., Park, C.K., Lee, S.H., Im, S.A., Kim, J.E., et al. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients. Int. J. Cancer 136 (2015), 162–171.
6. Anders, S., Huber, W., Differential expression analysis for sequence count data. Genome Biol., 11, 2010, R106.
7. Bajic, G., Degn, S.E., Thiel, S., Andersen, G.R., Complement activation, regulation, and molecular basis for complement-related diseases. EMBO J. 34 (2015), 2735–2757.
8. Bao, L., Wang, Y., Haas, M., Quigg, R.J., Distinct roles for C3a and C5a in complement-induced tubulointerstitial injury. Kidney Int. 80 (2011), 524–534.
9. Berasain, C., Avila, M.A., Amphiregulin. Semin. Cell Dev. Biol. 28 (2014), 31–41.
10. Bos, P.D., Zhang, X.H., Nadal, C., Shu, W., Gomis, R.R., Nguyen, D.X., Minn, A.J., van de Vijver, M.J., Gerald, W.L., Foekens, J.A., Massagué, J., Genes that mediate breast cancer metastasis to the brain. Nature 459 (2009), 1005–1009.
11. Bowman, R.L., Klemm, F., Akkari, L., Pyonteck, S.M., Sevenich, L., Quail, D.F., Dhara, S., Simpson, K., Gardner, E.E., Iacobuzio-Donahue, C.A., et al. Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies. Cell Rep. 17 (2016), 2445–2459.
12. Boyle, R., Thomas, M., Adams, J.H., Diffuse involvement of the leptomeninges by tumour–a clinical and pathological study of 63 cases. Postgrad. Med. J. 56 (1980), 149–158.
13. Brower, J.V., Saha, S., Rosenberg, S.A., Hullett, C.R., Ian Robins, H., Management of leptomeningeal metastases: prognostic factors and associated outcomes. J. Clin. Neurosci. 27 (2016), 130–137.
14. Chen, Q., Zhang, X.H., Massagué, J., Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell 20 (2011), 538–549.
15. Chen, Q., Boire, A., Jin, X., Valiente, M., Er, E.E., Lopez-Soto, A., Jacob, L.S., Patwa, R., Shah, H., Xu, K., et al. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature 533 (2016), 493–498.
16. Clarke, J.L., Perez, H.R., Jacks, L.M., Panageas, K.S., Deangelis, L.M., Leptomeningeal metastases in the MRI era. Neurology 74 (2010), 1449–1454.
17. Conyers, G., Milks, L., Conklyn, M., Showell, H., Cramer, E., A factor in serum lowers resistance and opens tight junctions of MDCK cells. Am. J. Physiol. 259 (1990), C577–C585.
18. Cunningham, K.E., Turner, J.R., Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann. N Y Acad. Sci. 1258 (2012), 34–42.
19. DeAngelis, L.M., Boutros, D., Leptomeningeal metastasis. Cancer Invest. 23 (2005), 145–154.
20. Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., Gingeras, T.R., STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29 (2013), 15–21.
21. Drouin, S.M., Kildsgaard, J., Haviland, J., Zabner, J., Jia, H.P., McCray, P.B. Jr., Tack, B.F., Wetsel, R.A., Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J. Immunol. 166 (2001), 2025–2032.
22. Floege, J., Amann, K., Primary glomerulonephritides. Lancet 387 (2016), 2036–2048.
23. Glover, R.L., Brook, A.L., Welch, M.R., Teaching NeuroImages: leptomeningeal lung carcinoma. Neurology 82 (2014), e183–e184.
24. Gupta, G.P., Nguyen, D.X., Chiang, A.C., Bos, P.D., Kim, J.Y., Nadal, C., Gomis, R.R., Manova-Todorova, K., Massagué, J., Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446 (2007), 765–770.
25. Humbles, A.A., Lu, B., Nilsson, C.A., Lilly, C., Israel, E., Fujiwara, Y., Gerard, N.P., Gerard, C., A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406 (2000), 998–1001.
26. Hutamekalin, P., Takeda, K., Tani, M., Tsuga, Y., Ogawa, N., Mizutani, N., Yoshino, S., Effect of the C3a-receptor antagonist SB 290157 on anti-OVA polyclonal antibody-induced arthritis. J. Pharmacol. Sci. 112 (2010), 56–63.
27. Kakonen, S.M., Selander, K.S., Chirgwin, J.M., Yin, J.J., Burns, S., Rankin, W.A., Grubbs, B.G., Dallas, M., Cui, Y., Guise, T.A., Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J. Biol. Chem. 277 (2002), 24571–24578.
28. Kang, Y., Siegel, P.M., Shu, W., Drobnjak, M., Kakonen, S.M., Cordón-Cardo, C., Guise, T.A., Massagué, J., A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3 (2003), 537–549.
29. Kesari, S., Batchelor, T.T., Leptomeningeal metastases. Neurol. Clin. 21 (2003), 25–66.
30. Khan, M.A., Nicolls, M.R., Surguladze, B., Saadoun, I., Complement components as potential therapeutic targets for asthma treatment. Respir. Med. 108 (2014), 543–549.
31. Kokkoris, C.P., Leptomeningeal carcinomatosis. How does cancer reach the pia-arachnoid?. Cancer 51 (1983), 154–160.
32. Lee, T.H., Avraham, H.K., Jiang, S., Avraham, S., Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability. J. Biol. Chem. 278 (2003), 5277–5284.
33. Lemos-González, Y., Rodríguez-Berrocal, F.J., Cordero, O.J., Gómez, C., Páez de la Cadena, M., Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma. Br. J. Cancer 96 (2007), 1569–1578.
34. Li, C., Chan, Y.R., Lipocalin 2 regulation and its complex role in inflammation and cancer. Cytokine 56 (2011), 435–441.
35. Lippoldt, A., Jansson, A., Kniesel, U., Andbjer, B., Andersson, A., Wolburg, H., Fuxe, K., Haller, H., Phorbol ester induced changes in tight and adherens junctions in the choroid plexus epithelium and in the ependyma. Brain Res. 854 (2000), 197–206.
36. Love, M.I., Huber, W., Anders, S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 2014, 550.
37. Malladi, S., Macalinao, D.G., Jin, X., He, L., Basnet, H., Zou, Y., de Stanchina, E., Massagué, J., Metastatic latency and immune evasion through autocrine inhibition of WNT. Cell 165 (2016), 45–60.
38. Massagué, J., Obenauf, A.C., Metastatic colonization by circulating tumour cells. Nature 529 (2016), 298–306.
39. Matter, K., Balda, M.S., Functional analysis of tight junctions. Methods 30 (2003), 228–234.
40. Merle, N.S., Church, S.E., Fremeaux-Bacchi, V., Roumenina, L.T., Complement system Part I - Molecular mechanisms of activation and regulation. Front. Immunol., 6, 2015, 262.
41. Mizutani, N., Nabe, T., Yoshino, S., Complement C3a regulates late asthmatic response and airway hyperresponsiveness in mice. J. Immunol. 183 (2009), 4039–4046.
42. Nguyen, D.X., Chiang, A.C., Zhang, X.H., Kim, J.Y., Kris, M.G., Ladanyi, M., Gerald, W.L., Massagué, J., WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 138 (2009), 51–62.
43. Ogrodowski, J.L., Hebert, L.A., Sedmak, D., Cosio, F.G., Tamerius, J., Kolb, W., Measurement of SC5b-9 in urine in patients with the nephrotic syndrome. Kidney Int. 40 (1991), 1141–1147.
44. Padua, D., Zhang, X.H., Wang, Q., Nadal, C., Gerald, W.L., Gomis, R.R., Massagué, J., TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133 (2008), 66–77.
45. Qian, B.Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L.R., Kaiser, E.A., Snyder, L.A., Pollard, J.W., CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475 (2011), 222–225.
46. Quail, D.F., Joyce, J.A., Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19 (2013), 1423–1437.
47. Reijneveld, J.C., Taphoorn, M.J., Voest, E.E., A simple mouse model for leptomeningeal metastases and repeated intrathecal therapy. J. Neurooncol. 42 (1999), 137–142.
48. Ricklin, D., Reis, E.S., Lambris, J.D., Complement in disease: a defence system turning offensive. Nat. Rev. Nephrol. 12 (2016), 383–401.
49. Schwartz, H., Blacher, E., Amer, M., Livneh, N., Abramovitz, L., Klein, A., Ben-Shushan, D., Soffer, S., Blazquez, R., Barrantes-Freer, A., et al. Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation. Cancer Res. 76 (2016), 4359–4371.
50. Scott, B.J., Kesari, S., Leptomeningeal metastases in breast cancer. Am. J. Cancer Res. 3 (2013), 117–126.
51. Sevenich, L., Bowman, R.L., Mason, S.D., Quail, D.F., Rapaport, F., Elie, B.T., Brogi, E., Brastianos, P.K., Hahn, W.C., Holsinger, L.J., et al. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat. Cell Biol. 16 (2014), 876–888.
52. Spector, R., Johanson, C., Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy. Pharm. Res. 23 (2006), 2515–2524.
53. Spector, R., Keep, R.F., Robert Snodgrass, S., Smith, Q.R., Johanson, C.E., A balanced view of choroid plexus structure and function: focus on adult humans. Exp. Neurol. 267 (2015), 78–86.
54. Spector, R., Robert Snodgrass, S., Johanson, C.E., A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans. Exp. Neurol. 273 (2015), 57–68.
55. Svatoňová, J., Bořecká, K., Adam, P., Lánská, V., Beta2-microglobulin as a diagnostic marker in cerebrospinal fluid: a follow-up study. Dis. Markers, 2014, 2014, 495402.
56. Tang, Z., Lu, B., Hatch, E., Sacks, S.H., Sheerin, N.S., C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J. Am. Soc. Nephrol. 20 (2009), 593–603.
57. Ushio, Y., Chernik, N.L., Posner, J.B., Shapiro, W.R., Meningeal carcinomatosis: development of an experimental model. J. Neuropathol. Exp. Neurol. 36 (1977), 228–244.
58. Valiente, M., Obenauf, A.C., Jin, X., Chen, Q., Zhang, X.H., Lee, D.J., Chaft, J.E., Kris, M.G., Huse, J.T., Brogi, E., Massagué, J., Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 156 (2014), 1002–1016.
59. Waki, F., Ando, M., Takashima, A., Yonemori, K., Nokihara, H., Miyake, M., Tateishi, U., Tsuta, K., Shimada, Y., Fujiwara, Y., Tamura, T., Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J. Neurooncol. 93 (2009), 205–212.
60. Walbert, T., Groves, M.D., Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment. Future Oncol. 6 (2010), 287–297.
61. Waning, D.L., Guise, T.A., Molecular mechanisms of bone metastasis and associated muscle weakness. Clin. Cancer Res. 20 (2014), 3071–3077.
62. Wculek, S.K., Malanchi, I., Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 528 (2015), 413–417.
63. Wessels, M.R., Butko, P., Ma, M., Warren, H.B., Lage, A.L., Carroll, M.C., Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 92 (1995), 11490–11494.
64. Zhang, L., Zhang, S., Yao, J., Lowery, F.J., Zhang, Q., Huang, W.C., Li, P., Li, M., Wang, X., Zhang, C., et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527 (2015), 100–104.